Old Web
English
Sign In
Acemap
>
Paper
>
Response Signature to the CD95-Ligand Inhibitor Asunercept Involve Low Serum P53 and Rankl
Response Signature to the CD95-Ligand Inhibitor Asunercept Involve Low Serum P53 and Rankl
2017
Thomas Luft
Aleksandar Radujkovic
Daniel Nowak
Harald Fricke
Claudia Kunz
Wolf-Karsten Hofmann
Florian Nolte
Peter Dreger
Tobias Boch
Keywords:
Fas receptor
RANKL
Cancer research
Ligand
Biology
cd95 ligand
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]